Sermorelin vs Ipamorelin vs Tesamorelin: Key Differences (2026)
Sermorelin vs Ipamorelin vs Tesamorelin: Key Differences (2026) Sermorelin vs ipamorelin vs tesamorelin compared for beginners: how these three growth hormone peptides differ in structure, receptor, mechanism, and published research. Sermorelin vs Ipamorelin v
This comparison does not assign a generated winner or score.
Sermorelin vs Ipamorelin vs Tesamorelin: Key Differences (2026) Sermorelin vs ipamorelin vs tesamorelin compared for beginners: how these three growth hormone peptides differ in structure, receptor, mechanism, and published research. Sermorelin vs Ipamorelin vs Tesamorelin: Key Differences (2026) Sermorelin vs ipamorelin vs tesamorelin compared for beginners: how these three growth hormone peptides differ in structure, receptor, mechanism, and published research. Sermorelin vs ipamorelin vs tesamorelin is one of the most common comparisons in growth hormone peptide research, and the core difference is straightforward: sermorelin and tesamorelin are GHRH analogs, while ipamorelin is a ghrelin mimetic. That single distinction, the receptor each one targets, explains almost everything else about how these three peptides behave in published studies. This guide breaks down each peptide, compares their structure, mechanism, and research status side by side. Updated for 2026. If you are completely new to this space, the beginner's guide to peptides is a useful starting point before diving into the comparisons below. Sermorelin vs Ipamorelin vs Tesamorelin: Quick Comparison Sermorelin, ipamorelin, and tesamorelin all increase the secretion of growth hormone (GH) from the pituitary gland, but they fall into two different peptide families that reach that result through different receptors. The table below summarizes how the three compare across the characteristics researchers look at most. Characteristic Sermorelin Ipamorelin Tesamorelin Peptide class GHRH analog Ghrelin mimetic (GHRP) Stabilized GHRH analog Amino acids 29 5 (pentapeptide) 44 Receptor target GHRH receptor Ghrelin receptor (GHS-R1a) Reported half-life Very short (minutes) Around 2 hours Longer than native GHRH Regulatory status FDA approved 1997, later discontinued Research compound only FDA approved 2010 Main research focus GH and IGF-1 signaling Selective GH release Visceral adipose tissue, metabolic markers The sections that follow explain each row in beginner-friendly terms, starting with what each peptide actually is. What Is Sermorelin? Sermorelin is a 29-amino acid peptide that copies the first 29 amino acids of human growth hormone-releasing hormone (GHRH), the natural signal your hypothalamus uses to tell the pituitary gland to release growth hormone. Because it is the active fragment of a hormone your body already makes, sermorelin is often described in the literature as the prototypical growth hormone secretagogue, a term for any compound that triggers GH secretion. It binds the GHRH receptor on pituitary cells and works through the Gs protein and cyclic AMP pathway, as outlined in a review of growth hormone secretagogues. A practical detail for beginners: sermorelin has a very short half-life, on the order of minutes, which researchers have characterized in pharmacokinetic studies of GHRH(1-29). Because it relies on the pituitary's own machinery, the GH release it produces follows the body's natural pulsing rhythm rather than overriding it. Sermorelin was approved by the U.S. FDA in 1997 in the context of pediatric growth hormone deficiency, and the original product was later discontinued for commercial reas